Let's be real here, this is a multiple phase 3 Biotech, one already commenced funded by the WHO, one due to commence in the coming days/weeks, and 2 in the planning/organising stage and we outstanding previous data, and our market cap is $50m. it is criminally undervalued. Yes a few (including me) was disappointed with the share price action after the last trial (which still garnered good results) we have been presented with the buying opportunity of a lifetime. I never expected to own any more DXB shares going into previous trial results but I've been accumulating like a mad man ever since. Unbelievable
DXB Chart, page-9
Add DXB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
45.5¢ |
Change
0.055(13.8%) |
Mkt cap ! $250.1M | |||
| Open | High | Low | Value | Volume |
| 40.5¢ | 47.0¢ | 40.3¢ | $5.392M | 12.10M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 14351 | 45.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 46.0¢ | 28878 | 5 |
View Market Depth
| Last trade - 16.10pm 30/05/2024 (20 minute delay) ? |
|
|||||
|
Last
45.3¢ |
Change
0.055 ( 13.1 %) |
||||
| Open | High | Low | Volume | ||
| 40.5¢ | 47.0¢ | 40.0¢ | 7666660 | ||
| Last updated 15.59pm 30/05/2024 ? | |||||
| DXB (ASX) Chart |